UPDATE : Thursday, August 6, 2020
Celltrion’s annual revenue surpassed ₩1 trillion in 2019
Celltrion, the nation’s leading biosimilar manufacturer, said its annual sa...
by Jeong Sae-im  |  2020-02-20 15:47
Prescription of Celltrion’s Remsima SC started in Germany
Celltrion Healthcare, the distribution and marketing unit of Korea’s biosim...
by Jeong Sae-im  |  2020-02-18 16:05
Korea University analyzes 5,000 cancer patients’ genomic data 
Korea University’s state-supported precision medicine project group, dubbed...
by Kim Yun-mi  |  2020-02-11 15:49
Sillajen's loss more than doubles due to Pexa-Vec trial failure
Sillajen’s losses more than doubled last year as the company failed its pha...
by Jeong Sae-im  |  2020-02-03 16:08
Kolon CEO arrested for mislabeling Invossa’s ingredient
A local court issued an arrest warrant for Kolon Life Science CEO Lee Woo-s...
by Jeong Sae-im  |  2020-02-03 15:34
Interpark embarks on organoid business
“We will develop organoid-based new medicines and realize customized precis...
by Park Gi-taek  |  2020-01-27 11:18
Samsung BioLogics’ annual sales up 30% on contract research growth
Samsung BioLogics saw its earnings surge last year, as it pursued more cont...
by Jeong Sae-im  |  2020-01-23 14:47
Celltrion Group to build biopharmaceutical plant in China
Celltrion Group said that it plans to build a biopharmaceutical factory in ...
by Lee Han-soo  |  2020-01-21 18:00
Korea’s biopharma power shines at JP Morgan Healthcare meet
Korean pharmaceutical and biotech companies showed off their technological ...
by Jeong Sae-im  |  2020-01-17 15:20
HLB stocks fall in after-hours trading due to interview on rivoceranib
HLB, a Kosdaq-listed firm, said it would introduce new anticancer pipelines...
by Jeong Sae-im  |  2020-01-16 15:46
Mundipharma to commercialize Samsung Bioepis’ biosimilar in Hong Kong, Taiwan
Mundipharma said that it has entered into a partnership with Samsung Bioepi...
by Lee Han-soo  |  2020-01-13 16:23
BioMarin seeks license for gene therapy to treat hemophilia
The world might be one step closer to the eradication of hemophilia.BioMari...
by Kim Yun-mi  |  2020-01-06 16:44
[New Year Special] Biotech rookies may shake up market cap rankings
Korean biotech companies, which drove up the buying spree on the Kosdaq mar...
by Jeong Sae-im  |  2020-01-02 14:31
Humedix wins patent on new anti-aging material
Humedix said it has won a local patent on a new substance called “nicotinam...
by Jeong Sae-im  |  2019-12-26 14:31
Vaxcell-Bio Therapeutics passes tech review for Kosdaq debut
Vaxcell-Bio Therapeutics, an immunotherapy developer, said it has passed th...
by Jeong Sae-im  |  2019-12-23 15:42
Samsung Bioepis’ Ontruzant 1st biosimilar to win WHO's PQ certification
Samsung Bioepis announced that Ontruzant, a trastuzumab biosimilar (Origina...
by Lee Han-soo  |  2019-12-20 16:29
Kolon appeals Invossa’s safety in pleading at court
Kolon Life Science is working flat out to prove the safety of Invossa-K, th...
by Jeong Sae-im  |  2019-12-20 14:57
4 firms to offer up to 56 direct-to-consumer genetic testing services
The government said it has allowed four companies, including Theragen Etex ...
by Jeong Sae-im  |  2019-12-19 16:40
Psomagen-Macrogen consortium acquires uBiome's patents, data
Psomagen and Macrogen said that they have acquired uBiome's 246 microbi...
by Lee Han-soo  |  2019-12-18 16:56
Venture capital investment in biomedical sector to hit record this year
Despite disappointing clinical trial failures by major biotech firms, ventu...
by Jeong Sae-im  |  2019-12-17 14:20
Back to Top